SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185185-17-000392
Filing Date
2017-02-16
Accepted
2017-02-16 19:19:09
Documents
1
Period of Report
2017-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4-hausman021617.html 4  
1 OWNERSHIP DOCUMENT form4-hausman021617.xml 4 8990
  Complete submission text file 0001185185-17-000392.txt   10733
Mailing Address 825 THIRD AVE 40TH FL NEW YORK NY 10022
Business Address
HAUSMAN MARVIN S MD (Reporting) CIK: 0001067956 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52864 | Film No.: 17619419

Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 971-228-0709
Entia Biosciences, Inc. (Issuer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products